Otoneurological presentations of COVID-19

Shinde, Kiran Jaywant; Karanth, Tulasi Kota; Yeolekar, Aditya

doi:10.1136/bcr-2021-241893

Cited by 2 publications

(3 citation statements)

References 35 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Tools had 8 items for case reports and 10 for case series. Included case reports ( n = 39) had a mean score of 6.385 ± 1.41 with scores ranging from 2 to 8 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 10 case series had a mean score of 5.60 ± 2.01, and scores ranged from 3 to 9. 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 The detailed results of the quality assessment are provided in Supporting Information: File S1 .…”

Section: Methodsmentioning

confidence: 99%

“…Tools had 8 items for case reports and 10 for case series. Included case reports ( n = 39) had a mean score of 6.385 ± 1.41 with scores ranging from 2 to 8 12–50 10 case series had a mean score of 5.60 ± 2.01, and scores ranged from 3 to 9 51–59 . The detailed results of the quality assessment are provided in Supporting Information: File .…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Facial palsy as a manifestation of COVID‐19: A systematic review of cases

Khurshid

Sohail

et al. 2022

Health Science Reports

View full text Add to dashboard Cite

Background and Aims Facial palsy is a rare complication of the COVID‐19 infection. Herein, we conducted a systematic review of all published cases of facial palsy post‐COVID‐19 infection in an attempt to educate the general population and medical practitioners regarding the likely occurrence of facial palsy in COVID‐19 patients, its detection, effective treatment plan, and prognosis of the condition. Methods We searched PubMed, Google Scholar, and Directory of Open Access Journals (DOAJ) from December 1, 2019 to September 21, 2021. Results We included 49 studies bearing accounts of 75 cases who had facial palsy. The mean age of patients was 42.9 ± 19.59 years, with a male‐to‐female ratio of 8:7. The majority of the cases were reported from Brazil ( n = 14), USA ( n = 9), Turkey ( n = 9), and Spain ( n = 9). Noticeably, 30.14% of COVID‐19 patients were diagnosed with Guillain‐Barré syndrome. In total, 22.97% of patients complained of bilateral facial paralysis ( n = 17), whereas ipsilateral paralysis was observed in 77.03% ( n = 57). These were common complaints of Lagophthalmos, otalgia, facial drooping, dysarthria, and compromised forehead wrinkling. The treatment regimen mainly included the use of corticosteroids ( n = 51) (69.86%), antivirals ( n = 23) (31.51%), IVIG ( n = 18) (24.66%), antibiotics ( n = 13) (17.81%), antiretroviral ( n = 9) (12.33%), and antimalarial ( n = 8) (10.96%) medications. In all, 35.62% of patients ( n = 26) adhered to a combination of antiviral and corticosteroid‐based therapy. Positive treatment outcomes were observed in 83.58% ( n = 56) of cases. In contrast, 10 patients (14.93%) showed nonsignificant recovery, out of which 3 (4.48%) died from the disease. Conclusion The association of facial palsy with COVID‐19 is controversial and therefore requires further investigation and published work to confirm a causal relationship. However, physicians should not overlook the likelihood of facial palsy post‐COVID‐19 infection and treat it accordingly.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Facial palsy as a manifestation of COVID‐19: A systematic review of cases

Khurshid

Sohail

et al. 2022

Health Science Reports

View full text Add to dashboard Cite

show abstract

“…In this review, we have found eighteen papers reporting some diagnosed vestibular dysfunction (Table 1). The primary pathology described within the reports has been BPPV [Abdelrahman and Shafik, 2021;Maslovara and Košec, 2021;Picciotti et al, 2021;Cetin, 2022] and vestibular neuronitis [Malayala and Raza, 2020;Vanaparthy et al, 2020;Aasfara et al, 2021;Giannantonio et al, 2021;Shinde et al, 2021;Mat et al, 2023]. Some cases of labyrinthitis [Gerstacker et al, 2021;Perret et al, 2021], acute vestibular syndrome [Zaffina et al, 2021], and 1 case of acute bilateral vestibulopathy have also been reported [Lee et al, 2022].…”

Section: Otoneurological Findings In Sars-cov-2 Patientsmentioning

confidence: 99%

COVID-19 and Vestibular Symptoms and Assessment: A Review

Aedo-Sánchez,

Gutiérrez,

Aguilar-Vidal

2023

Audiol Neurotol

View full text Add to dashboard Cite

Background: The current pandemic of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in significant morbidity and mortality primarily associated with respiratory failure. However, it has also been reported that COVID-19 can evolve into a nervous system infection. The direct and indirect mechanisms of damage associated with SARS-CoV-2 neuropathogenesis could affect our sensory functionality, including hearing and balance. Summary: In order to investigate a possible association between SARS-CoV-2 viral infection and possible damage to the vestibular system, this review describes the main findings related to diagnosing and evaluating otoneurological pathologies. Key Messages: The clinical evidence shows that SARS-CoV-2 causes acute damage to the vestibular system that would not leave significant sequelae. Recovery is similar to vestibular pathologies such as vestibular neuronitis and benign paroxysmal positional vertigo. Further basic science, clinical, and translational research is needed to verify and understand the short- and long-term effects of COVID-19 on vestibular function.

show abstract

Otoneurological presentations of COVID-19

Cited by 2 publications

References 35 publications

Facial palsy as a manifestation of COVID‐19: A systematic review of cases

Facial palsy as a manifestation of COVID‐19: A systematic review of cases

COVID-19 and Vestibular Symptoms and Assessment: A Review

Contact Info

Product

Resources

About